Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-084265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-02 | 2026-02-26 | SRPT | Estepan Ian Michael | COO | M - OptEx | $13.71 | +7,450 | 200.8K | +4% | +$102.1K |
| DM | 2026-03-02 | 2026-02-26 | SRPT | Estepan Ian Michael | COO | M - OptEx | $0.00 | -7,450 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | M | A | 2,069 | $13.71 | 195,369 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-26 | M | A | 5,381 | $13.71 | 200,750 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-02-26 | M | D | 5,381 | $0.00 | 0 | D | $13.71 · 2017-02-28 to 2026-02-28 | 5,381 Common Stock | |
| 4 | Derivative | Stock Option (right to buy) | 2026-02-26 | M | D | 2,069 | $0.00 | 0 | D | $13.71 · 2017-02-28 to 2026-02-28 | 2,069 Common Stock |